Cencora (COR) Total Non-Current Liabilities (2009 - 2026)
Cencora (COR) posted Total Non-Current Liabilities of -$3.1 billion for Q1 2026, down 4.27% on a QoQ basis from -$3.0 billion in Q4 2025, and down 9.97% year-over-year from -$3.5 billion in Q1 2025.
Cencora (COR) Total Non-Current Liabilities (2009 - 2026) Analysis & Trends
Cencora's Total Non-Current Liabilities history runs 18 years deep, the most recent figure standing at -$3.1 billion for Q1 2026.
- Quarterly Total Non-Current Liabilities fell 9.97% year-over-year to -$3.1 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$3.1 billion (down 9.97% YoY) and the FY2025 annual result came in at -$2.9 billion, down 1020.43% from the prior year.
- Total Non-Current Liabilities was -$3.1 billion for Q1 2026 at Cencora, down from -$3.0 billion in the prior quarter.
- Across five years, Total Non-Current Liabilities topped out at $320.5 million in Q3 2024 and bottomed at -$5.4 billion in Q2 2022.
- A 5-year average of -$2.0 billion and a median of -$1.5 billion in 2024 frame the typical range for Total Non-Current Liabilities.
- Annual changes were most pronounced in 2022 — Total Non-Current Liabilities surged 203.1% — and 2023, when it tumbled 2972.33%.
- Cencora's Total Non-Current Liabilities stood at $145.3 million in 2022, then tumbled by 2972.33% to -$4.2 billion in 2023, then surged by 64.32% to -$1.5 billion in 2024, then plunged by 100.51% to -$3.0 billion in 2025, then retreated by 4.27% to -$3.1 billion in 2026.
- Business Quant data shows COR's Total Non-Current Liabilities at -$3.1 billion in Q1 2026, -$3.0 billion in Q4 2025, and -$2.9 billion in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Mckesson | 105.15 Bn | 101.18 Bn | 4.04 Bn | -2.37 Bn |
| 2 | Cencora | 60.58 Bn | 58.40 Bn | 3.59 Bn | -3.11 Bn |
| 3 | Cardinal Health | 53.81 Bn | 49.87 Bn | 2.50 Bn | - |
| 4 | Henry Schein | 9.71 Bn | 9.57 Bn | 1.07 Bn | 6.05 Bn |
| 5 | Akso Health | 3.28 Bn | 3.28 Bn | - | 2,565.00 |
| 6 | 111 | 651.73 Mn | 572.63 Mn | 23.58 Mn | 279.68 Mn |
| 7 | Accendra Health | 248.02 Mn | -88.86 Mn | 278.03 Mn | 2.79 Bn |
| 8 | Edap Tms | 230.14 Mn | 215.14 Mn | 8.15 Mn | 58.52 Mn |
| 9 | VitaNova Life Sciences | 11.51 Mn | 11.01 Mn | 316,343.00 | - |
| 10 | Cosmos Health | 9.57 Mn | 7.41 Mn | 1.38 Mn | 40.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3.11 Bn |
| Dec 31, 2025 | -2.99 Bn |
| Sep 30, 2025 | -2.95 Bn |
| Jun 30, 2025 | -3.64 Bn |
| Mar 31, 2025 | -2.83 Bn |
| Dec 31, 2024 | -1.49 Bn |
| Sep 30, 2024 | 320.47 Mn |
| Jun 30, 2024 | -4.15 Bn |
| Mar 31, 2024 | -1.37 Bn |
| Dec 31, 2023 | -4.17 Bn |
| Sep 30, 2023 | -1.30 Bn |
| Jun 30, 2023 | -1.25 Bn |
| Mar 31, 2023 | -564.79 Mn |
| Dec 31, 2022 | 145.29 Mn |
| Sep 30, 2022 | 147.18 Mn |
| Jun 30, 2022 | -5.40 Bn |
| Mar 31, 2022 | 287.83 Mn |
| Dec 31, 2021 | -5.50 Bn |
| Sep 30, 2021 | -5.55 Bn |
| Jun 30, 2021 | 188.78 Mn |